Top Companies in Cell Isolation Market

The cell isolation market is projected to reach USD 7.97 billion by 2031 from USD 4.39 billion in 2026. The market is expected to grow at a CAGR of 12.7% from 2026 to 2031.

Danaher (US), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (US), BD (US), Sartorius AG (Germany), Agilent Technologies, Inc. (US), Bio-Rad Laboratories, Inc. (US), QIAGEN (Netherlands), F. Hoffmann-La Roche Ltd (Switzerland), Revvity (US), and Corning Incorporated (US) are the key players in this market.

To know about the assumptions considered for the study download the pdf brochure

These market players have adopted various approaches, including product launches, collaborations, acquisitions, agreements, and expansions, to enhance their market positions. In March 2026, Danaher and SR-TIGET launched a collaboration under the Danaher Beacon to advance next-generation genomic medicine platforms. The initiative focuses on lentiviral gene transfer and targeted gene editing of hematopoietic stem cells, with an emphasis on automating cell manipulation and improving processes across cell and gene therapy workflows.

 In September 2025, Merck opened a USD 176.5 million filtration manufacturing facility in Blarney, Cork. The site includes a 3,000 m² cleanroom and supports production of filtration products used in manufacturing vaccines, monoclonal antibodies, and emerging modalities such as cell and gene therapies.

Thermo Fisher Scientific Inc. (US): Thermo Fisher Scientific offers a broad cell isolation portfolio spanning Dynabeads magnetic beads, Gibco CTS Dynabeads, cell isolation kits, magnetic separation reagents, KingFisher automation-compatible workflows, and cell culture support products. Its offerings support applications such as immune cell isolation, T-cell enrichment, stem cell research, cell therapy development, single-cell analysis, and translational research. The company emphasizes magnetic bead-based separation workflows that help researchers isolate viable target cell populations with reproducibility, scalability, and compatibility with downstream cell analysis and expansion.

Danaher Corporation (US): Danaher participates in the cell isolation market through its life sciences businesses, including Cytiva and Beckman Coulter Life Sciences. Cytiva provides automated, functionally closed-cell processing platforms, such as the Sepax C-Pro and Sefia systems, used in cell isolation, enrichment, washing, and cell therapy manufacturing workflows. Beckman Coulter Life Sciences supports the market through flow cytometry and cell sorting platforms such as the CytoFLEX SRT benchtop cell sorter. Together, Danaher’s portfolio supports research and clinical workflows requiring high-purity cell populations, automation, reduced contamination risk, and integration with downstream cell therapy processing.

Merck KGaA (Germany): Merck, through its Life Science business, provides cell isolation and separation products, including density gradient media, magnetic microsphere-based separation materials, Ficoll media, Histopaque, Percoll, and cell culture support reagents. Its portfolio supports workflows such as leukocyte separation, mammalian cell isolation, organelle isolation, sample preparation, and downstream cell culture or analysis. The company’s offerings are used by academic laboratories, biopharmaceutical researchers, and clinical research groups requiring reliable sample preparation, cell enrichment, and separation media for reproducible cell isolation workflows.

Market Ranking

The cell isolation market is competitive, with leading life sciences, flow cytometry, and cell processing companies driving innovation and adoption. Key players include Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), and Merck KGaA (Germany). Thermo Fisher Scientific offers integrated cell isolation solutions across Dynabeads magnetic beads, Gibco CTS Dynabeads, magnetic separation reagents, cell isolation kits, and automated sample preparation platforms, supporting immune cell isolation, stem cell research, single-cell analysis, and cell therapy workflows. Danaher Corporation strengthens the market through Cytiva and Beckman Coulter Life Sciences, offering automated cell-processing systems, closed-cell isolation platforms, flow cytometers, and cell sorters that support high-purity cell separation and clinical-scale cell-therapy workflows. Merck KGaA contributes through its broad portfolio of density gradient media, including Ficoll, Histopaque, and Percoll; magnetic microspheres; enzymes; and workflow-enabling consumables used in cell separation, enrichment, and downstream sample preparation. Collectively, these companies enhance access to advanced cell isolation solutions, improve workflow reproducibility, reduce manual variability, and support the generation of viable, high-purity cell populations across pharmaceutical, biotechnology, clinical, and academic research settings.

Related Reports:

Cell Isolation Market/Cell Separation Market by Product [Consumables (Media, Beads), Instrument (Centrifuges, Filtration)], Cell Type (Stem Cell), Source, Technique, Application (IVD, Research, CGT), End User, Competition, Region - Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]